John Merritt

John Merritt is currently a Scientist at Cyagen and a Board Member at Yerba Buena Community Benefit District. Prior to these roles, John served as President of the Board of Directors at Cubix Yerba Buena and held positions at various biotech companies such as Eureka Therapeutics, Jupiter Therapeutics, and Applied Molecular Transport. John has a Master's in Translational Medicine from the University of California, Berkeley and University of California, San Francisco. John's educational background includes a Bachelor of Science in Biochemistry from Temple University and a High School Diploma from San Mateo High School.